Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02727127 · ClinicalTrials.gov registry record
Brain Ion Homeostasis, Lithium and Bipolar Disorder
A clinical trial, sponsored by NYU Langone Health.
- Terminated
- Registry status
- 26
- Enrollment target
NCT02727127 is a clinical trial that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 26 participants.
The verdict
NCT02727127 was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- 26 participants
- Enrollment target
Study Summary
In this project, investigators intend to carry out the first simultaneous, in vivo, imaging study of lithium content and sodium ion homeostasis in the brain of Bipolar Disorder (BPD) patients under Lithium therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-09-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02727127
The ClinicalTrials.gov registry entry for NCT02727127 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02727127 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02727127 about?
NCT02727127 is a clinical study titled "Brain Ion Homeostasis, Lithium and Bipolar Disorder". In this project, investigators intend to carry out the first simultaneous, in vivo, imaging study of lithium content and sodium ion homeostasis in the brain of Bipolar Disorder (BPD) patients under Lithium therapy.
What is the current status of trial NCT02727127?
This trial is currently terminated. The enrollment target is 26 participants. The study started on 2015-09. Estimated completion is 2019-09-11.
Who is sponsoring clinical trial NCT02727127?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.